ProQR Therapeutics PRQR
NASDAQ PRQR
$1.26 -0.05 (-3.82%)
At close: Nov 11, 2026 · 4:00 PM EST

ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014)

Updated

ProQR Therapeutics' Change in Account Payables was $464,552 in the quarter ended Sep 30, 2014, up 293.9% from $117,928 a year earlier.

Analysis

ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 ProQR Therapeutics 138.02 Mn -322.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 464,552.00
Sep 30, 2013 117,928.43
API Access

ProQR Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=PRQR&period=max&api_key=YOUR_API_KEY